Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Article type: Research Article
Authors: Zhang, Ximenga | Cai, Xiaoyinga | Shi, Xiaoleia | Zheng, Zhenyangb | Zhang, Aiwua | Guo, Junliangc | Fang, Yannana; *
Affiliations: [a] Department of Neurology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China | [b] Department of Neurology, Fujian Medical University Union Hospital, Fuzhou, China | [c] Zhongshan School of Medicine, Sun Yat-Sen University, Guangzhou, China
Correspondence: [*] Correspondence to: Yannan Fang, Department of Neurology, The First Affiliated Hospital, Sun Yat-sen University, NO. 2 Zhongshan Road, Guangzhou, 510080, China. E-mail: fyn2012@126.com.
Abstract: Cognitive dysfunction has been shown to be associated with many risk factors, such as smoking, diabetes, and body mass index. Chronic obstructive pulmonary disease (COPD), a common disease within the elderly population, has also been found to be related to cognitive decline. However, whether COPD is a risk factor of cognitive dysfunction is not well established. The purpose of this meta-analysis is to investigate the role COPD plays in cognitive dysfunction. PubMed, Cochrane library and Web of Science databases were searched. Three cohort studies and eleven cross-sectional studies were found to be eligible. According to our results, COPD patients had a higher risk of cognitive dysfunction than controls (OR [odds ratio]: 1.72; 95% CI, 1.12–2.65; p = 0.01). The exacerbation of COPD was strongly correlated with cognitive decline. COPD patients performed worse than controls on the Mini– Mental State Examination test, but the results were not statistically significant (OR: –0.79; 95% CI, [–1.78, 0.19]; p = 0.11). Thus, more attention should be given to the occurrence of cognitive decline in COPD patients. The prevention and control of COPD exacerbation are critical.
Keywords: Chronic obstructive pulmonary disease, cognition, dementia, meta-analysis
DOI: 10.3233/JAD-150735
Journal: Journal of Alzheimer's Disease, vol. 52, no. 1, pp. 101-111, 2016
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
sales@iospress.com
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
info@iospress.nl
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office info@iospress.nl
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
china@iospress.cn
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
如果您在出版方面需要帮助或有任何建, 件至: editorial@iospress.nl